Skip to main content

Better Therapeutics, Inc. (BTTX)

NASDAQ: BTTX · Delayed Price · USD
7.09
0.03 (0.42%)
At close: Nov 30, 2021 4:00 PM
7.00
-0.09 (-1.27%)
Pre-market:Dec 1, 2021 7:09 AM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Revenue
0.010.02
Revenue Growth
-55.56%-
Cost of Revenue
0.680.9
Gross Profit
-0.67-0.88
Selling, General & Admin
2.672.6
Research & Development
2.982.29
Operating Expenses
5.654.89
Operating Income
-6.32-5.77
Interest Expense / Income
0.10.01
Other Expense / Income
-0.190
Pretax Income
-6.23-5.78
Income Tax
0.150
Net Income
-6.39-5.78
Preferred Dividends
1.511.38
Net Income Common
-7.89-7.16
Shares Outstanding (Basic)
55
Shares Outstanding (Diluted)
55
Shares Change
5.87%-
EPS (Basic)
-1.57-1.51
EPS (Diluted)
-1.57-1.51
Free Cash Flow Per Share
-1.61-1.89
Gross Margin
-8425.00%-4888.89%
Operating Margin
-79037.50%-32072.22%
Profit Margin
-79837.50%-32133.33%
Free Cash Flow Margin
-100987.50%-49738.89%
Effective Tax Rate
-2.45%0.00%
EBITDA
-6.06-5.7
EBITDA Margin
-75737.50%-31672.22%
EBIT
-6.13-5.77
EBIT Margin
-76675.00%-32072.22%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).